Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12277942 | 0.79 | MCL1 (0.37) | KDM4EALDH1A1NPC1HSD17B10MCL1 | |
| SCHEMBL12278442 | 0.75 | PIM1 (0.39) | KDM4EALDH1A1NPC1HSD17B10MCL1 | |
| SCHEMBL13519125 | 0.72 | MEN1 (0.57) | KDM4EALDH1A1NPC1HSD17B10MCL1 | |
| SCHEMBL12278482 | 0.70 | CYP3A4 (0.41) | KDM4EALDH1A1NPC1HSD17B10MCL1 | |
| SCHEMBL12278873 | 0.70 | KDM4E (0.42) | KDM4EALDH1A1NPC1HSD17B10KMT2A | |
| SCHEMBL827392 | 0.69 | MAOB (0.50) | ALDH1A1MAOACA12CA1CA4 | |
| SCHEMBL827096 | 0.68 | CYP2A6 (0.48) | KDM4EALDH1A1NPC1HSD17B10KMT2A | |
| SCHEMBL16403660 | 0.68 | MCL1 (0.42) | KDM4EALDH1A1HSD17B10MCL1KMT2A | |
| SCHEMBL18290424 | 0.68 | F2RL3 (0.43) | NPC1MAPTRAB9ACA12CA1 | |
| SCHEMBL12278631 | 0.67 | CYP3A4 (0.44) | KDM4EALDH1A1HSD17B10MCL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10985327-B2 | Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor | FUJIFILM CORPORATION (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20190237677-A1 | MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR | FUJIFILM CORPORATION (JP) | 2019-08-01 | — | — | US | disclosed |
| US-20190221754-A1 | BOTTOM GATE TYPE ORGANIC SEMICONDUCTOR TRANSISTOR | FUJIFILM CORPORATION (JP) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237677-A1 | MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR | OR10J3, ALK, MSMO1 | KDM4E 2164/4885ALDH1A1 3182/4885NPC1 2154/4885 |
| US-10985327-B2 | Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor | OR10J3, ALK, MSMO1 | KDM4E 2164/4885ALDH1A1 3182/4885NPC1 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.